Palisade Bio Quote, Financials, Valuation and Earnings

Palisade Bio Price Quote


Palisade Bio Key Stats

Palisade Bio (PALI) is a Sell

Day range:
$1.40 - $1.53
52-week range:
$1.27 - $30.60
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Palisade Bio Make?

Data Unavailable

Is Palisade Bio Growing As A Company?

Data Unavailable

Palisade Bio Stock Price Performance

  • Did Palisade Bio Stock Go Up Last Month?
    Palisade Bio share price went down by -6.88% last month
  • Did PALI's Share Price Rise Over The Last Year?
    PALI share price fell by -94.71% over the past 1 year

What Is Palisade Bio 52-Week High & Low?

Palisade Bio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Palisade Bio?

  • How Much Debt Does Palisade Bio Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Palisade Bio Have?
    Cash and short term investments quarterly total is $13.3M
  • What Is Palisade Bio’s Book Value Per Share?
    Book value per share is 3.01

Is Palisade Bio Cash Flow Positive?

  • What Is PALI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.1M
  • What Is Palisade Bio’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $19.8M
  • What Is Palisade Bio’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Palisade Bio Return On Invested Capital

Data Unavailable

Palisade Bio Earnings Date & Stock Price

  • What Is Palisade Bio's Stock Price Today?
    A single share of PALI can be purchased today for 1.49
  • What Is Palisade Bio’s Stock Symbol?
    Palisade Bio trades on the nasdaq under the ticker symbol: PALI
  • When Is Palisade Bio’s Next Earnings Date?
    The next quarterly earnings date for Palisade Bio is scheduled on August 15, 2023
  • When Is PALI's next ex-dividend date?
    Palisade Bio's next ex-dividend date is June 7, 2023
  • How To Buy Palisade Bio Stock?
    You can buy Palisade Bio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Palisade Bio Competitors

  • Who Are Palisade Bio's Competitors?
    Below is a list of companies who compete with Palisade Bio or are related in some way:
    • AngioDynamics Inc (ANGO)
    • Brainstorm Cell Therapeutics Inc (BCLI)
    • Paratek Pharmaceuticals Inc (PRTK)
    • Pyxis Oncology Inc (PYXS)

Palisade Bio Dividend Yield

Data Unavailable

Palisade Bio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 18.18%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.50
Upside from Last Price: 604.7%

Major Shareholders

  • How many PALI shares are owned by institutional investors?
    162.2K PALI shares are owned by institutional investors
  • How many PALI shares are owned by insiders?
    92.1K PALI shares are owned by insiders